IMCR
Income statement / Annual
Last year (2024), Immunocore Holdings plc's total revenue was $310.20 M,
an increase of 24.37% from the previous year.
In 2024, Immunocore Holdings plc's net income was -$51.09 M.
See Immunocore Holdings plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$310.20 M |
$249.43 M |
$143.74 M |
$26.52 M |
$30.11 M |
$25.67 M |
$23.65 M |
| Cost of Revenue |
$2.73 M
|
$1.04 M
|
$454,000.00
|
$73.23 M
|
$74.81 M
|
$99.99 M
|
$0.00
|
| Gross Profit |
$307.47 M
|
$248.39 M
|
$143.28 M
|
-$46.71 M
|
-$44.70 M
|
-$74.32 M
|
$23.65 M
|
| Gross Profit Ratio |
0.99
|
1
|
1
|
-1.76
|
-1.48
|
-2.9
|
1
|
| Research and Development Expenses |
$222.15 M
|
$163.55 M
|
$89.17 M
|
$73.23 M
|
$74.81 M
|
$99.99 M
|
$83.58 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$88.40 M
|
$45.74 M
|
$44.18 M
|
$34.16 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$99.99 M
|
$83.58 M
|
| Selling, General & Administrative Expenses |
$155.78 M
|
$144.50 M
|
$93.72 M
|
$88.40 M
|
$45.74 M
|
$44.18 M
|
$34.16 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$3,000.00
|
$57,000.00
|
-$1.15 M
|
$185,000.00
|
$5.60 M
|
| Operating Expenses |
$377.93 M
|
$308.04 M
|
$182.89 M
|
$161.68 M
|
$119.40 M
|
$144.17 M
|
$117.73 M
|
| Cost And Expenses |
$380.66 M
|
$309.08 M
|
$183.34 M
|
$161.68 M
|
$119.40 M
|
$144.17 M
|
$117.73 M
|
| Interest Income |
$25.62 M
|
$17.99 M
|
$3.15 M
|
$47,000.00
|
$706,000.00
|
$1.40 M
|
$822,000.00
|
| Interest Expense |
$18.84 M
|
$5.15 M
|
$7.69 M
|
$5.81 M
|
$3.11 M
|
$3.80 M
|
$842,000.00
|
| Depreciation & Amortization |
$0.00
|
$4.09 M
|
$5.34 M
|
$7.59 M
|
$8.98 M
|
$9.21 M
|
$6.71 M
|
| EBITDA |
-$70.46 M |
-$51.65 M |
-$38.35 M |
-$166.72 M |
-$102.59 M |
-$113.18 M |
-$86.75 M |
| EBITDA Ratio |
-0.23
|
-0.21
|
-0.25
|
-5.09
|
-2.51
|
-4.2
|
-3.42
|
| Operating Income Ratio |
-0.23
|
-0.24
|
-0.28
|
-5.1
|
-2.86
|
-4.61
|
-3.95
|
| Total Other Income/Expenses Net |
$17.52 M
|
-$1.24 M
|
$5.79 M
|
$33.66 M
|
-$1.17 M
|
-$7.87 M
|
$5.28 M
|
| Income Before Tax |
-$52.94 M
|
-$60.89 M
|
-$44.15 M
|
-$140.93 M
|
-$87.36 M
|
-$126.19 M
|
-$88.18 M
|
| Income Before Tax Ratio |
-0.17
|
-0.24
|
-0.31
|
-5.31
|
-2.9
|
-4.92
|
-3.73
|
| Income Tax Expense |
-$1.85 M
|
-$5.60 M
|
-$2.92 M
|
-$9.41 M
|
-$13.27 M
|
-$22.26 M
|
-$16.55 M
|
| Net Income |
-$51.09 M
|
-$55.29 M
|
-$41.22 M
|
-$131.52 M
|
-$74.09 M
|
-$103.93 M
|
-$71.63 M
|
| Net Income Ratio |
-0.16
|
-0.22
|
-0.29
|
-4.96
|
-2.46
|
-4.05
|
-3.03
|
| EPS |
-1.02 |
-1.13 |
-0.9 |
-3.1 |
-2.33 |
-3.81 |
-2.62 |
| EPS Diluted |
-1.02 |
-1.13 |
-0.9 |
-3 |
-2.33 |
-3.81 |
-2.62 |
| Weighted Average Shares Out |
$49.99 M
|
$48.89 M
|
$45.71 M
|
$42.49 M
|
$31.78 M
|
$27.31 M
|
$27.31 M
|
| Weighted Average Shares Out Diluted |
$49.99 M
|
$48.89 M
|
$45.71 M
|
$43.86 M
|
$31.78 M
|
$27.31 M
|
$27.31 M
|
| Link |
|
|
|
|
|
|
|
